Saudi market index closes

TASI
10,326.47
+18.10 (+0.18%)
MT30
1,400.46
+2.64 (+0.19%)
NOMU (Capped)
22,054.14
+105.57 (+0.48%)
Sukuk
890.39
-0.62 (-0.07%)

Source: Saudi Exchange data supplied for this session. Not live prices.

GoFinsa

Welcome to GoFinsa!

FAKEEH CARE

4017

GoFinsa Saudi Stock Investment Strength Index

55%
Investment strength
Explore the GoFinsa Saudi Stocks Index →

Analytical index, not a guaranteed return or buy recommendation.

30.6 SAR
Change: -0.02 SARChange %: -0.07 %Trading volume: 94,919 sharesTrades: 639 Open: 30.64 SARHigh: 30.8 SARLow: 30.3 SAR
Last available trade from session · 2026-11-12

FAKEEH CARE stock (4017) price and technical analysis

GoFinsa tracks FAKEEH CARE under symbol 4017, with the latest available price at 30.6 SAR. This page includes multi-timeframe charts, technical analysis and related market news.

Market data source: بيانات جلسة السوق السعودي المقدمة من المستخدم · Latest available update: 2026-11-12 · Delayed market data

Fakeeh Care (4017) Stock: Price, GoFinsa Rating and News

GoFinsa provides a guide to Fakeeh Care, listed under ticker 4017, with an overview of its economic sector and factors to consider when researching the stock.

About Fakeeh Care and Its Business

Fakeeh Care (ticker 4017) operates in the Saudi market. Company descriptions list activities including manufacturing or distributing pharmaceutical products, hospitals, healthcare, pharmacies and pharmaceutical products. Other areas or products mentioned in those descriptions include dermatological treatments, education and training. This overview describes activities and products cited in company information; it does not mean that all of them contribute equally to revenue or that they have produced specific financial results.

Fakeeh Care Stock Information

Fakeeh Care shares trade on the Saudi Exchange under ticker 4017. The company belongs to the healthcare sector. Reviewing official disclosures and financial results can help investors understand the company’s position and the development of its business.

Fakeeh Care’s Business and Company Information

The company is classified in the healthcare sector of the Saudi market. Refer to its annual reports and official disclosures for information about its activities, revenue sources and operational developments.

The Healthcare Sector in the Saudi Economy

The performance of listed healthcare companies can be affected by demand for their products and services, operating costs, competition, and economic and regulatory conditions. Each company’s exposure to these factors depends on its business model.

How to Read the Stock’s Financial Results

Compare revenue, earnings, cash flows and debt across several reporting periods, and examine the reasons for changes rather than relying on the results of a single quarter. Review official announcements for information about material events.

Factors That May Affect the Share Price

Fakeeh Care’s share price may be influenced by company results and disclosures, trends in the Saudi market, interest rates and investor expectations. A share-price movement alone does not indicate an improvement in operating performance.

Investment Risks

Potential risks include share-price volatility, changes in costs, weaker demand, competition and regulatory changes. Actual risks depend on the company’s activities and financial position.

Stock Strength According to the GoFinsa Saudi Stocks Index

The stock’s recorded rating in the GoFinsa GFSI is 57%. This is an independent analytical rating, not a guarantee of returns or a personal recommendation to buy.

Investing in Saudi Stocks

The Saudi stock market includes companies across a range of economic sectors. Investors can benefit from reviewing disclosures, comparing financial valuations, diversifying risk and defining their investment horizon before making a decision.

Following Company News

News and disclosures concerning Fakeeh Care can be followed through news sources and official information available on GoFinsa. Check the date of each item and how directly it relates to the company.

Fakeeh Care’s Reference Price

The recorded reference price is SAR 34.28 as of 2026-10-08. This is a historical price, not a live quote or a confirmed price for current trading.

Fakeeh Care’s Rating in the GoFinsa GFSI

The stock’s rating in the GoFinsa GFSI is 57%. This is GoFinsa’s research rating and is not a recommendation to buy or sell.

Overview of the Healthcare Sector

Fakeeh Care belongs to the healthcare sector of the Saudi Exchange. Companies in the sector are affected by demand, competition, costs, and economic and regulatory conditions, though revenue sources and risk exposures vary from one company to another.

Trading Through XTB and the Risks

What Does Fakeeh Care Do?

Fakeeh Care (4017) belongs to the healthcare sector. The company’s potential research scope includes operating hospitals and medical centres and providing treatment services. Verify the precise activities and subsidiaries against the company’s latest official profile before publication.

Where Does Fakeeh Care’s Revenue Come From?

When analysing Fakeeh Care’s business model, review the following potential sources of income where supported by the company’s financial statements: revenue from medical services, patient visit volumes, occupancy and case mix. Listing these items does not establish that each is an actual contributor to the company’s revenue.

Factors That May Affect Fakeeh Care’s Performance

Indicators relevant to Fakeeh Care’s business may include occupancy rates, expansion, staffing costs and contracts with insurance companies. Compare actual trends in the company’s results across multiple periods. Do not infer growth or profitability without documented figures.

What to Check in the Annual Disclosure

When researching Fakeeh Care (4017), first identify the date of the latest annual report, then review the description of actual activities, operating segments and revenue-recognition policy. Read the notes to the financial statements rather than relying only on management’s summary; the notes may disclose obligations or events not apparent from headline figures. Confirm the identity of the listed entity, its subsidiaries and the nature of their operations before attributing an activity or project to the company. Conditions in the healthcare sector should not be treated as evidence of revenue growth at this company unless supported by its published results.

How to Distinguish Genuine Growth from Accounting Changes

To analyse Fakeeh Care, compare results for several equivalent periods and watch for non-recurring items, reclassifications and changes in the scope of consolidation. Higher revenue does not necessarily mean improved profitability if cost of sales or expenses have risen faster. Examine operating and net profit margins, then review management’s explanations in the notes. Without reliable and up-to-date financial statements, these are analytical steps, not claims about Fakeeh Care’s actual performance.

Cash Flows and the Ability to Fund Operations

When reviewing Fakeeh Care’s financial information, distinguish accounting profit from cash generated by operations. Examine net operating cash flows, working-capital changes, capital expenditure and financing costs. A company may report profits while cash declines because of higher receivables or inventory, or project-related payments. Conversely, cash flow may be temporarily affected by the timing of collections and payments. The company’s liquidity or solvency cannot be assessed without the relevant financial statements and notes.

Debt and Financing Costs: Key Questions

If Fakeeh Care has financing liabilities, start by identifying their maturities, the split between short- and long-term debt, borrowing costs and any contractual covenants. Consider how earnings and cash flows might respond to interest-rate changes, taking into account whether financing instruments have fixed or variable rates. The importance of these questions depends on the company’s healthcare business model. This guide does not assume that the company has any particular level of debt or risk.

Comparing the Stock with Sector Peers Without Misleading Conclusions

For a fair comparison of Fakeeh Care, choose companies with similar activities, revenue mix, scale and regulatory context. Compare revenue growth, margins, return on capital and cash flows, while accounting for differences in accounting practices and leverage. A lower price-to-earnings multiple than a peer’s is not, by itself, proof that a stock is cheaper; the difference may reflect growth expectations, risk or earnings quality. If a company has losses or non-recurring profits, some valuation multiples may not be suitable for comparison.

How to Read the Reference Price and Its Date

The reference price shown in this guide is historical and dated; it is not a live bid or ask. When assessing Fakeeh Care, check which trading session the price relates to and whether capital changes, a share split or distributions may affect historical comparisons. Do not confuse the previous closing price with the latest trade or the session’s average price. If market data is not current, its date should be clearly shown, and a dated figure should not be used to infer a new daily trend.

Build Scenarios Instead of Predicting a Specific Price

Investors can consider three scenarios for Fakeeh Care: improving business conditions, conditions remaining broadly unchanged, and weaker demand or margins. For each scenario, set measurable assumptions, such as sales volumes, input costs or financing expenses, and compare the resulting analysis with published financial statements when available. Do not set a target price without a valuation model and documented inputs, or present the positive scenario as an expected outcome. The purpose is to understand how the investment may respond to new information.

Checklist Before Making an Investment Decision

Before investing in Fakeeh Care, confirm the ticker 4017, the company’s identity and the price date, and review the latest material disclosure, financial results and auditor’s notes, if available. Distinguish GoFinsa’s research rating from the suitability of an investment for your personal circumstances. Consider your time horizon, tolerance for loss and exposure to the healthcare sector in your portfolio. Check broker fees and the type of financial instrument: owning shares directly differs from trading derivatives or contracts for difference, which may involve additional risks.

أسئلة شائعة عن الشركة

What is Fakeeh Care’s stock ticker?

Its ticker on the Saudi Exchange is 4017.

Which sector does Fakeeh Care belong to?

The stock belongs to the healthcare sector.

Is the GoFinsa rating a buy recommendation?

No. The rating is an analytical tool; it is not a personal investment recommendation or a guarantee of future performance.

Frequently asked questions about FAKEEH CARE (4017)

What is the price of FAKEEH CARE (4017)?

The latest price available in GoFinsa data is 30.6 SAR. Price status may be live or delayed depending on the market and data provider.

What does the technical analysis for FAKEEH CARE (4017) show?

There is currently insufficient data to produce technical analysis for this instrument.

What is the GoFinsa.com General Index for FAKEEH CARE?

The GoFinsa.com General Index is currently unavailable for this instrument.